Sana Biotechnology will present clinical data on UP421, a hypoimmune islet cell therapy for type 1 diabetes, at an upcoming symposium.

--Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, today announced data from the AMDS PERSEVERE clinical trial was presented in a Late-Breaking Science ...

The presentation was featured in the ISCT public announcement, which indicated that the data were "carefully reviewed and selected by the ISCT 2025 Planning Faculty, to explore the latest ...

Lassen Therapeutics Announces Oral Presentation of Phase I Data of LASN01, an IL-11 Receptor-Blocking Antibody for Treatment of Pulmonary Fibrosis, at the American Thoracic Society 2023 Annual Meeting ...

The presentation highlighted interim data from the ongoing trial, which, as of the data cutoff date, has treated five patients in Cohort A with a low dose of 3x10 13 viral genomes (vg) per patient ...

The data were featured in an oral presentation at the American Diabetes Association (ADA) annual conference in Chicago as part of the symposium, “Innovation and Progress in Stem Cell-Derived ...

Four abstracts will report results from the PALSONIFY development program, including an oral presentation featuring open-label extension data from the registrational Phase 3 PATHFNDR trials.

Data presentation and consumer confidence Date: July 20, 2010 Source: University of Chicago Press Journals Summary: Is it better to present data in percentages (80% of 70) or as a frequency (56 ...